Cord blood stem cell improve functionality and quality of life in Ataxia patients
Investor Stem Cell
A new study published by the Journal of Translational Medicine reports on the effectiveness of cord blood-derived stem cells and physical therapy in the treatment of Hereditary Ataxia. Following treatment, patients with Hereditary Ataxia showed statistically significant improvements in functionality and quality of life after treatment.
Hereditary Ataxia is a neurodegenerative disorder that affects the cerebellum, brain stem, or spinal cord. Symptoms of the condition include a variety of functional impairments relating to speech, walking, swallowing, and other physical activities. Currently, there is no cure for this condition.